Semyon L Maksimov

Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study

V. Gushchin, A. Gintsburg, S. Fitilev, 2020, Vaccines.